Glenmark Pharmaceuticals Limited — Sirolimus Exporter Profile
Indian Pharmaceutical Exporter · #8 for Sirolimus · $214.5K export value · DGFT Verified
Glenmark Pharmaceuticals Limited is the #8 Indian exporter of Sirolimus with $214.5K in export value and 32 verified shipments. Glenmark Pharmaceuticals Limited holds a 1.4% market share in Sirolimus exports across 2 countries. The company exports 28 pharmaceutical products worth $205.5M across 14 therapeutic categories.
Glenmark Pharmaceuticals Limited — Sirolimus Export Profile: Buyers & Destinations
Where Does Glenmark Pharmaceuticals Limited Export Sirolimus?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $155.7K | 4 | 73.0% |
| UNITED STATES OF AMERICA | $57.3K | 2 | 26.9% |
| BRAZIL | $296 | 26 | 0.1% |
Glenmark Pharmaceuticals Limited exports Sirolimus to 3 countries. The largest destination is UNITED STATES accounting for 73.0% of Glenmark Pharmaceuticals Limited's Sirolimus shipments, followed by UNITED STATES OF AMERICA (26.9%) and BRAZIL (0.1%). These destinations reflect Glenmark Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.